ReviewCurrent gastroenterology reports2018
Gastric Antral Vascular Ectasia Pathogenesis and the Link to the Metabolic Syndrome.
Review in Current gastroenterology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 20 citations in OpenAlex.
- Risk factors for bleeding from gastric antral vascular ectasia.The Korean journal of internal medicine · 2026Article
- Article
- Initial treatment approaches for nodular gastric antral vascular ectasia: A comparison of endoscopic band ligation and thermal therapies.World journal of gastrointestinal endoscopy · 2025Article
- Role of endoscopy in the diagnosis and treatment of gastric mucosal lesions in liver cirrhosis patients.World journal of gastrointestinal endoscopy · 2025Review
- A case report of gastric antral vascular ectasia treated by endoscopic band ligation combined with lauromacrogol injection.Medicine · 2025Article
- Higher waist circumference as a risk factor for rebleeding of small bowel angiodysplasia.Translational gastroenterology and hepatology · 2025Article
- Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.Journal of cellular and molecular medicine · 2024Article
- The misclassification of gastric antral vascular ectasia.Journal of clinical and translational research · 2022Article
- The classification of gastric antral vascular ectasia in cirrhotic patients by Versatile Intelligent Staining Technology.Egyptian liver journal · 2022Article
- An Unexpected Association: Might GAVE Pave the Way to How the Metabolic Syndrome Behaves.Clinical liver disease · 2021Review
- Gastric Antral Vascular Ectasia and Vitamin D Deficiency: New Associated Disease and Proposed Pathogenetic Mechanisms.Digestive diseases and sciences · 2021Article
- Gastric antral vascular ectasia in a patient with lupus undergoing hemodialysis: a case report.BMC nephrology · 2020Article
- Is endoscopic band ligation the gold standard for gastric antral vascular ectasia?Endoscopy international open · 2019Article
- Gastric Antral Vascular Ectasia as an Unusual Cause of Iron Deficiency Anemia in Primary Sjögren's Syndrome.International journal of applied & basic medical researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewGastric antral vascular ectasia (GAVE) is a well-described source of chronic blood loss. We aim to review the previously hypothesized etiologies of GAVE and focus on recent proposed mechanisms, including metabolic syndrome. We will support these theories with newly discovered clinical associations and possible therapeutic implications. RECENT
findingsHistorically, GAVE has been associated with connective tissue disease and liver disease. Based on these associations and its histologic appearance, GAVE has presumed to be caused by mechanical- and hormonally mediated injury. Recent findings have been notable for a clinical association with aspects of the metabolic syndrome. Therefore, the pathogenic etiology may be akin to aspects of the metabolic syndrome via microvascular injury and neoangiogenesis. The potential etiologies of GAVE include hypergastrinemia, mechanical injury, and microvascular injury with neovascular proliferation particularly in the metabolic syndrome. Further research is needed to evaluate these proposed mechanisms and potential targets for treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.